Yvonne Perlberg
Directeur/Membre du Conseil chez EnGeneIC Pty Ltd.
Postes actifs de Yvonne Perlberg
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
EnGeneIC Pty Ltd.
 EnGeneIC Pty Ltd. BiotechnologyHealth Technology EnGeneIC Pty Ltd. develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer. It offers targeted drug delivery, gene silencing, canine cancers and principal characteristics technology solutions. The company was founded by Jennifer A. MacDiarmid and Himanshu Brahmbhatt in 2001 and is headquartered in Sydney, Australia. | Directeur/Membre du Conseil | 25/01/2016 | - |
Historique de carrière de Yvonne Perlberg
Formation de Yvonne Perlberg
| Indiana University | Undergraduate Degree |
| Central Michigan University | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| Australie | 2 |
Opérationnelle
| Director/Board Member | 1 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
EnGeneIC Pty Ltd.
EnGeneIC Pty Ltd. BiotechnologyHealth Technology EnGeneIC Pty Ltd. develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer. It offers targeted drug delivery, gene silencing, canine cancers and principal characteristics technology solutions. The company was founded by Jennifer A. MacDiarmid and Himanshu Brahmbhatt in 2001 and is headquartered in Sydney, Australia. | Health Technology |
- Bourse
- Insiders
- Yvonne Perlberg
- Expérience
